Zobrazeno 1 - 10
of 93
pro vyhledávání: '"oncotarget"'
Publikováno v:
OncoTargets and therapy
Osteosarcoma (OS) is the most common bone malignant tumor with a high rate of lung metastasis and principally emerges in children and adolescents. Although neoadjuvant chemotherapy is widely used around the world, a high rate of chemoresistance occur
Publikováno v:
OncoTargets and Therapy, Vol Volume 11, Pp 1553-1561 (2018)
Yucheng Fu,1 Wei Yu,2 Hongliu Cai,1 Anwei Lu1 1Department of Surgical Intensive Care Unit, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang Province, People’s Republic of China; 2Department of Orthopedics,
Autor:
Huricha Jin, Zhiming Cui, Wei Zhao, Chengniu Wang, Guofeng Bao, Hao Zhu, Dawei Xu, Genxiang Liu, Daoran Cui, Fei Wang, Jianbo Fan
Publikováno v:
Oncotarget
It is needed to explore novel biological markers for early diagnosis and treatment of human osteosarcoma. Sphingosine kinase 2 (SphK2) expression and potential functions in osteosarcoma were studied. We demonstrate that SphK2 is over-expressed in mul
Autor:
Ana Blanca, Nuno Vau, Giampaolo Tortora, Chiara Ciccarese, Rodolfo Montironi, Liang Cheng, Jorge Fonseca, Maria Rosaria Raspollini, Marina Scarpelli, Francesco Massari, Antonio Lopez-Beltran
Publikováno v:
Expert Opinion on Therapeutic Targets. 21:401-414
Despite more than 30 years of research on p53 resulting in50,000 publications, we are now beginning to figure out the complexity of the p53 pathway, gene ontology and conformational structure of the molecule. Recent years brought great advances in p5
Publikováno v:
Oncotarget
// Yan Wang 1 , Wen-Sheng Cai 2 , Luonan Chen 3 , Guanyu Wang 1 1 Department of Biology, Southern University of Science and Technology, Shenzhen 518055, China 2 Research Center for Analytical Sciences, College of Chemistry, Nankai University, Tianjin
Publikováno v:
Frontiers in Pharmacology
Frontiers in Pharmacology, Vol 10 (2019)
Frontiers in Pharmacology, Vol 10 (2019)
Background: Colorectal cancer (CRC) is the malignant process that surges in the terminal part of gastrointestinal tract when adenomatous polyps convert to neoplastic cells able to infiltrate the submucosa. Despite the constant progress in applying pr
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Samuele Cheri, Luca Dalle Carbonare, Giovanni Malerba, Jessica Brandi, Vincenzo Degaetano, Antonio Mori, Giulio Innamorati, Daniela Cecconi, Monica Mottes, Michela Deiana, Maria Teresa Valenti, Valentina Masiero
Publikováno v:
Oncotarget
// Daniela Cecconi 1 , Luca Dalle Carbonare 2 , Antonio Mori 3 , Samuele Cheri 3 , Michela Deiana 3 , Jessica Brandi 1 , Vincenzo Degaetano 2 , Valentina Masiero 2 , Giulio Innamorati 2 , Monica Mottes 3 , Giovanni Malerba 3 and Maria Teresa Valenti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::08418a2c59ba0165620495a010b004ac
http://hdl.handle.net/11562/973490
http://hdl.handle.net/11562/973490
Autor:
Zhen, Lu, Yun-Hong, Xia, Min, Zhao, Bing, Zhang, Wen-Ting, Dai, Lu, Ding, Li-Xia, Hu, Jin-Ling, Bi, Guo-Lin, Jiang
Publikováno v:
Oncotarget
Tumor-specific hepatic stellate cells (tHSCs) positively participate in human hepatocellular carcinoma (HCC) tumorigenesis and progression. Our previous studies have shown that tHSCs co-culture with dendritic cells (DCs) induced DIgR2 (dendritic cell
Autor:
Henry Garcia, Geraldine M. Paszkiewicz, Angela Omelian, Mairead Commane, Katerina Gurova, Alfiya Safina, Carl Morrison, Daria Fleyshman, Katerina Kolesnikova
Publikováno v:
Oncotarget
Henry Garcia 1 , Daria Fleyshman 1 , Katerina Kolesnikova 1 , Alfiya Safina 1 , Mairead Commane 1 , Geraldine Paszkiewicz 1 , Angela Omelian 2 , Carl Morrison 2 , Kateryna Gurova 1 1 Department of Cell Stress Biology, Roswell Park Cancer Institute, E